This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rehfeld, J. F. Articles by Hilsted, L. Search for Related Content PubMed PubMed Citation Articles by Rehfeld, J. F. Articles by Hilsted, L.

Gastrin in Human Bronchogenic Carcinomas: Constant Expression but Variable Processing of Progastrin

Departments of Clinical Chemistry [J. F. R., L. H.] and Surgery (C) [L. B.], Rigshospitalet, University of Copenhagen, Denmark

Using a library of radioimmunoassays against essential sequences of human progastrin and procholecystokinin, we have examined the occurrence of gastrin, cholecystokinin, and their precursors in bronchogenic adenocarcinomas, large-cell, small-cell, and squamous-cell carcinomas (n = 17). Progastrin and some of its bioactive (i.e., -carboxyamidated) products were present in all tumors, irrespective of histological classification. The concentration of progastrin varied from 0.2 to 21.9 pmol/g tissue; glycine-extended intermediates constituted <0.1 to 0.5 pmol/g; and bioactive, carboxyamidated gastrin ranged from <0.1 to 6.1 pmol/g. Chromatography showed that the bioactive gastrins were exclusively gastrin-17 peptides, half of which were tyrosine O-sulfated. Neither procholecystokinin nor its processing products were found in the tumor extracts. Six samples of nonneoplastic human lung tissue contained traces of progastrin (range, <0.1–0.8 pmol/g), but neither bioactive gastrins nor any cholecystokinin. The results show that the gastrin gene is expressed in all classes of bronchogenic carcinomas. Due to incomplete posttranslational processing measurement of progastrin may be necessary to detect such expression.

¹ To whom correspondence should be addressed, at the Department of Clinical Chemistry (KK-3011), Rigshospitalet, DK-2100 Copenhagen, Denmark.

Received 10/31/88. Revised 1/30/89. Accepted 2/ 2/89.

This article has been cited by other articles:

				P.-T. Lee, P.-C. Liao, W.-C. Chang, and J. T. Tseng Epidermal Growth Factor Increases the Interaction between Nucleolin and Heterogeneous Nuclear Ribonucleoprotein K/Poly(C) Binding Protein 1 Complex to Regulate the Gastrin mRNA Turnover Mol. Biol. Cell, December 1, 2007; 18(12): 5004 - 5013. [Abstract] [Full Text] [PDF]

				T. J. Koh, J. K. Field, A. Varro, T. Liloglou, P. Fielding, G. Cui, J. Houghton, G. J. Dockray, and T. C. Wang Glycine-Extended Gastrin Promotes the Growth of Lung Cancer Cancer Res., January 1, 2004; 64(1): 196 - 201. [Abstract] [Full Text] [PDF]

				V. M. Stepan, D. F. Krametter, M. Matsushima, A. Todisco, J. Delvalle, and C. J. Dickinson Glycine-extended gastrin regulates HEK cell growth Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R572 - R581. [Abstract] [Full Text] [PDF]

				J. F. REHFELD The New Biology of Gastrointestinal Hormones Physiol Rev, October 1, 1998; 78(4): 1087 - 1108. [Abstract] [Full Text] [PDF]